# Saffron Sleep Quality Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/saffron-sleep-quality-meta-analysis-evidence-review
Category: evidence-review
Summary: Saffron Sleep Quality Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mix
Last reviewed: 2026-06-23
Reviewed by: Migaku Evidence Review
# Saffron Sleep Quality Meta-analysis: What the Evidence Says

## Quick Answer

Saffron Sleep Quality Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 narrative review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Efficacy and Safety of Herbal Supplements with Anxiolytic, Antidepressant, and Sedative Action: A Review of Clinical Data and Toxicological Risks | narrative review | 3 | 2026-02-28 | 10.3390/ph19030399 |
| Neuroprotective Effects of the Combination of Green Tea, Saffron, Docosahexaenoic Acid, and α-Lipoic Acid in an In Vitro Model of Parkinson's Disease. | preclinical study | 4 | 2026-03-15 | 10.1007/s12035-026-05800-4 |

## What The Sources Report

- Although these products are available without a prescription and are generally thought to be safe, there are pharmacological and toxicological risks associated with their use. [Căuș Maria-Nina (2026); evidence level 3]
- The differences in the regulatory framework allow for broad consumer access to plant-based products; it also creates potential gaps in safety monitoring and risk communication. [Căuș Maria-Nina (2026); evidence level 3]
- Levodopa remains the most effective therapy; however, it is associated with a wide range of side effects and shows little to no efficacy against non-motor symptoms. [Galla R (2026); evidence level 4]
- The results demonstrated that the combined treatment (Mix) significantly restored cell viability after 6-OHDA exposure and more effectively reduced oxidative and nitrosative stress, as well as lipid peroxidation, compared to single compounds. [Galla R (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For saffron sleep quality meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Căuș Maria-Nina (2026). Efficacy and Safety of Herbal Supplements with Anxiolytic, Antidepressant, and Sedative Action: A Review of Clinical Data and Toxicological Risks. DOI: 10.3390/ph19030399. PMCID: PMC13028908. PMID: 41901246. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13028908/
- Galla R (2026). Neuroprotective Effects of the Combination of Green Tea, Saffron, Docosahexaenoic Acid, and α-Lipoic Acid in an In Vitro Model of Parkinson's Disease.. DOI: 10.1007/s12035-026-05800-4. PMCID: PMC12989466. PMID: 41832920. https://pmc.ncbi.nlm.nih.gov/articles/PMC12989466/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.